Cargando…
Enhancement of human plasma glucosylceramide assay sensitivity using delipidized plasma
Glucosylceramide (GL-1) level in human has been considered as a surrogate biomarker for enzyme replacement and substrate reduction therapies (ERT and SRT) for Gaucher and Fabry patients. Due to the high endogenous level of GL-1 in human plasma, it is difficult to achieve the analytical sensitivity o...
Autores principales: | Zheng, Kefei, Ji, Allena, Chung, Lee Lee, Culm-Merdek, Kerry, Liu, Hanlan, Richards, Susan, Sung, Crystal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978213/ https://www.ncbi.nlm.nih.gov/pubmed/27547732 http://dx.doi.org/10.1016/j.ymgmr.2016.07.004 |
Ejemplares similares
-
Delipidation of Plasma Has Minimal Effects on Human Butyrylcholinesterase
por: Onder, Seda, et al.
Publicado: (2018) -
Glycosphingolipid Changes in Plasma in Parkinson's Disease Independent of Glucosylceramide Levels
por: te Vruchte, Danielle, et al.
Publicado: (2022) -
Low level of the plasma sphingolipid, glucosylceramide, is associated with thrombotic diseases
por: Deguchi, Hiroshi, et al.
Publicado: (2017) -
Optimised tissue clearing minimises distortion and destruction during tissue delipidation
por: Lee, Krit, et al.
Publicado: (2020) -
Differential Regulation of Glucosylceramide Synthesis and Efflux by Golgi and Plasma Membrane Bound ABCC10
por: Iqbal, Jahangir, et al.
Publicado: (2023)